Strides Pharma Science Limited (STAR) - Total Assets

Latest as of September 2025: Rs65.21 Billion INR ≈ $705.18 Million USD

Based on the latest financial reports, Strides Pharma Science Limited (STAR) holds total assets worth Rs65.21 Billion INR (≈ $705.18 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See STAR net asset value for net asset value and shareholders' equity analysis.

Strides Pharma Science Limited - Total Assets Trend (2005–2025)

This chart illustrates how Strides Pharma Science Limited's total assets have evolved over time, based on quarterly financial data.

Strides Pharma Science Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Strides Pharma Science Limited's total assets of Rs65.21 Billion consist of 51.2% current assets and 48.8% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	2.3%
Accounts Receivable	Rs12.03 Billion	19.9%
Inventory	Rs12.78 Billion	21.1%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs5.68 Billion	9.4%
Goodwill	Rs5.47 Billion	9.0%

Asset Composition Trend (2005–2025)

This chart illustrates how Strides Pharma Science Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Strides Pharma Science Limited (STAR) total market value.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Strides Pharma Science Limited's current assets represent 51.2% of total assets in 2025, an increase from 47.1% in 2005.
Cash Position: Cash and equivalents constituted 2.3% of total assets in 2025, down from 4.4% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 18.0% of total assets, an increase from 4.0% in 2005.
Asset Diversification: The largest asset category is inventory at 21.1% of total assets.

Strides Pharma Science Limited Competitors by Total Assets

Key competitors of Strides Pharma Science Limited based on total assets are shown below.

Company	Country	Total Assets
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥31.46 Billion
Yuhan Corp. KO:000100	Korea	₩3.05 Trillion
Tasly Pharmaceutical Group Co Ltd SHG:600535	China	CN¥15.34 Billion
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	China	CN¥15.32 Billion
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	China	CN¥10.96 Billion
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	China	CN¥1.54 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion
Cronos Group Inc TO:CRON	Canada	CA$1.18 Billion

Strides Pharma Science Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.15	1.04	0.93
Quick Ratio	0.64	0.64	0.59
Cash Ratio	0.00	0.00	0.00
Working Capital	Rs4.23 Billion	Rs1.30 Billion	Rs-1.89 Billion

Strides Pharma Science Limited - Advanced Valuation Insights

This section examines the relationship between Strides Pharma Science Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.90
Latest Market Cap to Assets Ratio	0.02
Asset Growth Rate (YoY)	3.6%
Total Assets	Rs60.49 Billion
Market Capitalization	$1.03 Billion USD

Valuation Analysis

Below Book Valuation: The market values Strides Pharma Science Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Strides Pharma Science Limited's assets grew by 3.6% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Strides Pharma Science Limited (2005–2025)

The table below shows the annual total assets of Strides Pharma Science Limited from 2005 to 2025.

Year	Total Assets	Change
2025-03-31	Rs60.49 Billion ≈ $654.15 Million	+3.58%
2024-03-31	Rs58.40 Billion ≈ $631.55 Million	-12.03%
2023-03-31	Rs66.38 Billion ≈ $717.92 Million	-4.84%
2022-03-31	Rs69.76 Billion ≈ $754.41 Million	-0.56%
2021-03-31	Rs70.15 Billion ≈ $758.65 Million	+14.03%
2020-03-31	Rs61.52 Billion ≈ $665.29 Million	-23.16%
2019-03-31	Rs80.06 Billion ≈ $865.77 Million	+22.34%
2018-03-31	Rs65.44 Billion ≈ $707.68 Million	-19.38%
2017-03-31	Rs81.17 Billion ≈ $877.80 Million	+5.98%
2016-03-31	Rs76.59 Billion ≈ $828.30 Million	+208.08%
2015-03-31	Rs24.86 Billion ≈ $268.86 Million	+18.44%
2014-03-31	Rs20.99 Billion ≈ $227.00 Million	-56.25%
2013-03-31	Rs47.98 Billion ≈ $518.84 Million	-12.20%
2012-03-31	Rs54.64 Billion ≈ $590.93 Million	+21.61%
2011-03-31	Rs44.93 Billion ≈ $485.94 Million	+39.12%
2010-03-31	Rs32.30 Billion ≈ $349.29 Million	+38.77%
2009-03-31	Rs23.27 Billion ≈ $251.70 Million	+14.46%
2008-03-31	Rs20.33 Billion ≈ $219.91 Million	+65.73%
2007-03-31	Rs12.27 Billion ≈ $132.69 Million	+31.10%
2006-03-31	Rs9.36 Billion ≈ $101.22 Million	+71.20%
2005-03-31	Rs5.47 Billion ≈ $59.12 Million	--

About Strides Pharma Science Limited

NSE:STAR India Drug Manufacturers - Specialty & Generic

Market Cap

$1.03 Billion

Rs95.56 Billion INR

Market Cap Rank

#8959 Global

#427 in India

Share Price

Rs1036.80

Change (1 day)

-1.58%

52-Week Range

Rs635.25 - Rs1098.55

All Time High

Rs1643.30